Delivery Order SPE2DB22D1106-SPE2DB24FEEQ0
Award Date 3/13/24
Potential Completion Date 3/14/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of buprenorphine-naloxone film in 30-count packages. The contract is a Delivery Order with a Firm Fixed Price, valued at $1,124.33 and with a completion date of July 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for buprenorphine-naloxone 8-2mg film in 30-count packages, with a ceiling value of $1,064.64 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 0.3 mg/mL buprenorphine vials. The contract has a ceiling value of $1,389.00 and a period of performance ending on June 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.19 to AmerisourceBergen Drug Corp for the supply of Buprenorphine-Naloxone 12-3mg film strips (30-count packages) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive, firm fixed-price delivery order will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Buprenorphine 0.3 mg/mL vials valued at $1,058.70. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is a child contract under AmerisourceBergen's substantial...
- This federal contract award, valued at $1,744.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,559,897,112 tablets of 2 mg Buprenorphine sublingual tablets, with a completion date of February 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company has established itself as a key vendor for...
- The Defense Logistics Agency awarded a $272,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 packages containing 4-1mg films of buprenorphine-naloxone. The place of performance for this single award delivery order is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance spans from July 21, 2023 through July 24, 2023. No major subcontractors or set aside designations were identified. This delivery order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the supply of Buprenorphine 0.3 mg/ml vials, a prescription medication used to treat opioid dependence. The contract has a firm fixed price and a ceiling value of $1,974.67. It is not a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Buprenorphine 20 mcg/hr transdermal patches. The $2,056.78 contract has a completion date of July 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded a $1,323.06 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Suboxone 8 mg-2 mg sublingual film in quantities of 30, with a completion date of June 23, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price transaction and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The product will be performed at the...